_what-is-hydromorphone-and-is-it-an-alternative-to-victoria39s-second-injecting-room.jpg "What is hydromorphone, and is it an alternative to Victoria's second injecting room? from ibrutinib medication Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1:51
👁 View: 280K times
✓ Published: 27-Apr-2024
👁 View: 280K times
✓ Published: 27-Apr-2024
Description:
Victoria will soon trial a new medication to try and help long-term users break their addiction. When Premier Jacinta Alan reneged on plans to set up a second safe injecting room in Melbourne this week. She committed to the trial of the pain killer Hydromorphone. Experts have welcomed it but are concerned about its small scope and the fact that it won’t begin for two years.
Victoria will soon trial a new medication to try and help long-term users break their addiction. When Premier Jacinta Alan reneged on plans to set up a second safe injecting room in Melbourne this week. She committed to the trial of the pain killer Hydromorphone. Experts have welcomed it but are concerned about its small scope and the fact that it won’t begin for two years.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_new-treatment-options-for-cll-patients.webp "In an exclusive interview, Dr. Tom Kipps, a CLL expert physician from the University of California in San Diego talks about new treatment options for CLL. Results from the Resonate Phase III study of Ibrutinib versus Ofatumumab in patients with relapsed or refractory Chronic Lymphocytic Leukemia was presented at the conference and the results were very positive for patients treated with Ibrutinib. Dr. Kipps goes on to explain that the study was a cross-over study so that patients could choose to")
_the-safety-and-efficacy-of-ibrutinib-for-the-treatment-of-cll.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_cll-chemotherapy-and-ibrutinib-based-regimens.webp "HMP Education")
_ibrutinib-resistance-mechanisms-and-options-in-cll.webp "HMP Education")
_the-latest-cll-treatments-and-therapies-with-dr-jan-burger.webp "Leukaemia Foundation - Blood Cancer Information")
_meet-the-new-billionaire-getting-rich-making-injectors-for-blockbuster-drugs-like-ozempic.webp "The runaway success of weight loss drugs took the markets by storm last year, spurring huge stock gains for drugmakers like Novo Nordisk, which makes Wegovy and Ozempic. Most patients take them at home in weekly injections, using plastic, pen-like devices known as autoinjectors, filled with the liquid medication and fitted with a tiny needle as wide as two human hairs.<br/><br/>As demand for the drugs soars, so does the need for those devices. That growth has now minted a new billionaire: Roger Samuelsson, the 60-year-old Swedish cofounder of Switzerland-based SHL Medical, one of the world’s largest manufacturers of autoinjectors. Forbes estimates he’s worth $3 billion, largely thanks to his 69% stake in the company he cofounded in 1989. The remaining 31% is held by Swedish private equity firm EQT—which has minted seven billionaires over the years—and Athos, the family office of the billionaire Struengmann brothers. Press-shy Samuelsson, who declined multiple requests for an interview, also enjoys fast cars (he raced in the 2016 Ferrari Challenge series) and owns the 414-foot megayacht Octopus, which he bought in 2021; the yacht was built for its first owner, Microsoft cofounder Paul Allen (d. 2018).<br/><br/>0:00 Introduction<br/>0:20 Who Is Roger Samuelsson?<br/>3:32 The Growing Market For Injectors<br/>5:50 Who Is The Competition In The Space<br/>8:50 What's Next For SHL Medical<br/>10:45 What's Next For Roger Samuelsson<br/><br/>Read the full story on Forbes: https://www.forbes.com/sites/giacomotognini/2024/04/12/meet-the-billionaire-owned-company-making-injectors-for-blockbuster-drugs-like-ozempic/?sh=5ba1ce857607<br/><br/>Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1<br/><br/>Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:<br/><br/>https://account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript<br/><br/>Stay Connected<br/>Forbes newsletters: https://newsletters.editorial.forbes.com<br/>Forbes on Facebook: http://fb.com/forbes<br/>Forbes Video on Twitter: http://www.twitter.com/forbes<br/>Forbes Video on Instagram: http://instagram.com/forbes<br/>More From Forbes:http://forbes.com<br/><br/>Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.")
⏲ 11:59 👁 4.2M
_calquence-acalabrutinib-ace-cl-001-ibrutinib-intolerant-cohort-dr-raval-md.webp "CALQUENCE (acalabrutinib)")
⏲ 18 minutes 7 seconds 👁 1.2K
_new-treatment-options-for-cll-patients.jpg)
_the-safety-and-efficacy-of-ibrutinib-for-the-treatment-of-cll.jpg)
_cll-chemotherapy-and-ibrutinib-based-regimens.jpg)
_ibrutinib-resistance-mechanisms-and-options-in-cll.jpg)
_the-latest-cll-treatments-and-therapies-with-dr-jan-burger.jpg)
_meet-the-new-billionaire-getting-rich-making-injectors-for-blockbuster-drugs-like-ozempic.jpg)
_calquence-acalabrutinib-ace-cl-001-ibrutinib-intolerant-cohort-dr-raval-md.jpg)
![[+]](/images/menu.gif){kind=small}